These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22311720)

  • 21. Temporal change of enhancement after gadolinium injection on contrast-enhanced CMR in reperfused acute myocardial infarction.
    Matsumoto H; Matsuda T; Miyamoto K; Shimada T; Ushimaru S; Mikuri M; Yamazaki T
    J Cardiol; 2015 Jan; 65(1):76-81. PubMed ID: 24861912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of angiographic, electrocardiographic and MRI methods to assess the area at risk in acute myocardial infarction.
    Versteylen MO; Bekkers SC; Smulders MW; Winkens B; Mihl C; Winkens MH; Leiner T; Waltenberger JL; Kim RJ; Gorgels AP
    Heart; 2012 Jan; 98(2):109-15. PubMed ID: 21930725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic validation of magnetic resonance assessment of myocardium at risk in non-ST-elevation myocardial infarction.
    Buckert D; Mariyadas M; Walcher T; Rasche V; Wöhrle J; Rottbauer W; Bernhardt P
    Int J Cardiovasc Imaging; 2013 Aug; 29(6):1295-301. PubMed ID: 23546649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction.
    Matsumoto H; Matsuda T; Miyamoto K; Shimada T; Mikuri M; Hiraoka Y
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):610-8. PubMed ID: 21679895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths.
    Khan JN; Nazir SA; Horsfield MA; Singh A; Kanagala P; Greenwood JP; Gershlick AH; McCann GP
    BMC Res Notes; 2015 Feb; 8():52. PubMed ID: 25889795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
    Kwong RY; Korlakunta H
    Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of the myocardial area at risk with pre- versus post-reperfusion imaging techniques in the pig model.
    Mewton N; Rapacchi S; Augeul L; Ferrera R; Loufouat J; Boussel L; Micolich A; Rioufol G; Revel D; Ovize M; Croisille P
    Basic Res Cardiol; 2011 Nov; 106(6):1247-57. PubMed ID: 21874556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging.
    Fuernau G; Zaehringer S; Eitel I; de Waha S; Droppa M; Desch S; Schuler G; Adams V; Thiele H
    Int J Cardiol; 2013 Sep; 167(5):2134-9. PubMed ID: 22704876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of myocardial salvage by myocardial perfusion SPECT and cardiac magnetic resonance--reference standards for ECG development.
    Engblom H; Aletras AH; Heiberg E; Arheden H; Carlsson M
    J Electrocardiol; 2014; 47(4):525-34. PubMed ID: 24866753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage.
    Arai AE
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):313-20. PubMed ID: 21821534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of technetium-99m sestamibi single photon emission computed tomography in acute myocardial infarction: measuring the efficacy of therapy.
    Miller TD; Sciagrà R; Gibbons RJ
    Q J Nucl Med Mol Imaging; 2010 Apr; 54(2):213-29. PubMed ID: 20588215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index.
    Ortiz-Pérez JT; Lee DC; Meyers SN; Davidson CJ; Bonow RO; Wu E
    JACC Cardiovasc Imaging; 2010 May; 3(5):491-500. PubMed ID: 20466344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.
    Dongworth RK; Campbell-Washburn AE; Cabrera-Fuentes HA; Bulluck H; Roberts T; Price AN; Hernández-Reséndiz S; Ordidge RJ; Thomas DL; Yellon DM; Lythgoe MF; Hausenloy DJ
    Sci Rep; 2017 May; 7(1):2271. PubMed ID: 28536472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrocardiographic infarct size assessment after thrombolysis: insights from the Acute Myocardial Infarction STudy ADenosine (AMISTAD) trial.
    Barbagelata A; Di Carli MF; Califf RM; Garg J; Birnbaum Y; Grinfeld L; Gibbons RJ; Granger CB; Goodman SG; Wagner GS; Mahaffey KW;
    Am Heart J; 2005 Oct; 150(4):659-65. PubMed ID: 16209961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of stress hyperglycemia on myocardial salvage in patients with ST-Elevation myocardial infarction: Cardiac magnetic resonance study.
    Meshref TS; Abd El-Aal RF; Ashry MA; Imam HM; Elden AB
    Indian Heart J; 2020; 72(5):462-465. PubMed ID: 33189215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The quantification of infarct size.
    Gibbons RJ; Valeti US; Araoz PA; Jaffe AS
    J Am Coll Cardiol; 2004 Oct; 44(8):1533-42. PubMed ID: 15489082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting myocardial salvage after primary PTCA: early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging.
    Sciagrà R; Bolognese L; Rovai D; Sestini S; Santoro GM; Cerisano G; Marini C; Buonamici P; Antoniucci D; Fazzini PF
    J Nucl Med; 1999 Mar; 40(3):363-70. PubMed ID: 10086696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification of viable myocardium delayed enhancement magnetic resonance imaging and 99Tcm-sestamibi or 18F-fluorodeoxyglucose single photon emission computed tomography].
    Zhao SH; Yan CW; Yang MF; Lu MJ; Jiang SL; Li SG; Zhang Y; Liu Q; Liu YQ; He ZX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1072-6. PubMed ID: 17274892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi.
    Ibrahim T; Nekolla SG; Hörnke M; Bülow HP; Dirschinger J; Schömig A; Schwaiger M
    J Am Coll Cardiol; 2005 Feb; 45(4):544-52. PubMed ID: 15708702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of Area at Risk Quantification by Cardiac Magnetic Resonance According to the Myocardial Infarction Territory.
    Fernández-Friera L; García-Ruiz JM; García-Álvarez A; Fernández-Jiménez R; Sánchez-González J; Rossello X; Gómez-Talavera S; López-Martín GJ; Pizarro G; Fuster V; Ibáñez B
    Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):323-330. PubMed ID: 27592277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.